[16日ロイター] - 米バイオ医薬品大手モデルナ(MRNA.O), opens new tabは16日、開発を進めている、メッセンジャーRNA（mRNA）テクノロジーに基づく季節性インフルエンザワクチンについて、臨床試験がまちまちだったと発表した。A型では強い ...

コロナ禍で活躍したmRNAワクチンの、さらに先へ 新型コロナウイルス（SARS-CoV-2）の世界的大流行において、mRNAワクチンは人類の叡智を結集し、前例のない速さで開発されました。この新しい技術は、パンデミックの抑制に大きく貢献した一方で、いくつかの ...

Aside from maybe high school biology classes, the first time many people heard of mRNA was during the pandemic because of the vital role MRNA technology played in COVID-19 vaccines. As the building ...

この資料は、モデルナ（マサチューセッツ州ケンブリッジ）が2022年9月1日（現地時間）に発表したものを日本語に翻訳したもので、報道関係者の皆さまに参考資料として提供するものです。資料の内容および解釈については、英語が優先されます。英語版は ...

HONG KONG, July 4, 2025 - (ACN Newswire) -Everest Medicines (HKEX: 1952.HK) recently unveiled major breakthroughs in its proprietary AI-powered mRNA platform during its 2025 R&D Day held in Shanghai.

Social media users in early December 2022 have falsely claimed that Albert Bourla, the CEO of Pfizer, has resigned after allegedly saying that mRNA vaccines are unsafe and ineffective. As of this ...

Since the announcements by federal health authorities earlier this year that federal mRNA vaccine funding will be curtailed, a fierce debate has taken place around the future of mRNA-based vaccines ...

Over the holiday period, the Guardian leader column is looking ahead at the themes of 2026. Today we examine how the White House’s war on vaccines has left the future of a key technology uncertain and ...

Scientists at Memorial Sloan Kettering Cancer Center have developed personalized mRNA vaccines for pancreatic cancer, with ...